Cardiovascular Anastomosis Devices Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

Cardiovascular anastomosis devices include automated connectors, sutureless anastomosis systems, and coupling tools used to join vessels during CABG and other cardiothoracic procedures. The market is estimated at $1.8 billion in 2025, growing at approximately 6.2% annually. Because no government agency publishes a standalone classification for these devices, sizing depends on private commercial research.

• •Estimated global value of $1.8 billion in 2025
• •Compound annual growth rate of approximately 6.2%
• •Market sizing relies on private research rather than official government statistics

The rising global burden of coronary artery disease continues to elevate CABG procedure volumes, directly supporting device demand. Aging populations in developed and emerging markets, combined with clinician preference for faster, reproducible anastomotic techniques, are accelerating adoption of automated and sutureless platforms. Procedural efficiency, reduced operative time, and improved graft patency outcomes further reinforce purchasing decisions among cardiac surgery centers.

• •Rising prevalence of coronary artery disease and aging populations
• •Surgeon preference for automated and sutureless anastomosis platforms
• •Efficiency gains including reduced operative time and improved graft patency

The market segments by product type into automated anastomosis devices, sutureless anastomosis systems, and accessory components, with proximal and distal connectors representing core revenue contributors. By application, CABG accounts for the majority share, while vascular and congenital heart repairs constitute emerging niches. North America leads on the back of high procedure volumes and established reimbursement pathways, followed by Europe, while Asia-Pacific is the fastest-growing region as surgical infrastructure expands.

• •CABG is the dominant application segment
• •North America holds the largest regional share
• •Asia-Pacific is the fastest-growing regional market

What are the recent trends and outlook?

Innovation is shifting toward bioresorbable materials, three-dimensional-printed device concepts, and elastomeric sealants that may reduce reliance on traditional suturing techniques. Adoption of minimally invasive and robotic-assisted cardiac surgery is expected to create new demand for compatible anastomosis connectors. With procedure volumes rising and technology evolving, the market outlook remains constructive, sustaining mid-single-digit annual growth through the end of the decade.

• •Emerging research in bioresorbable and 3D-printed anastomosis technologies
• •Growth in minimally invasive and robotic-assisted cardiac surgery
• •Continued mid-single-digit annual growth expected through the late 2020s